$KNW
KNOW LABS, INC.

2024 Q2 Form 10-Q Financial Statement

#000165495424006410 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.487M $2.551M
YoY Change 82.89% 13.74%
% of Gross Profit
Research & Development $1.349M $2.175M
YoY Change -28.23% -15.14%
% of Gross Profit
Depreciation & Amortization $20.64K $19.65K
YoY Change -62.09% -80.72%
% of Gross Profit
Operating Expenses $3.836M $4.726M
YoY Change 18.42% -1.67%
Operating Profit -$3.836M -$4.726M
YoY Change 18.42% -1.67%
Interest Expense $298.2K $716.8K
YoY Change 1168.55% 477.73%
% of Operating Profit
Other Income/Expense, Net -$267.6K -$671.6K
YoY Change -25.79% 441.26%
Pretax Income -$4.103M -$5.398M
YoY Change 13.99% 9.48%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.103M -$5.398M
YoY Change 13.99% 9.48%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 85.51M shares 81.35M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.130M $4.710M
YoY Change -45.79% -24.35%
Cash & Equivalents $2.130M $4.710M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.130M $4.710M
YoY Change -45.79% -24.35%
LONG-TERM ASSETS
Property, Plant & Equipment $88.67K $55.66K
YoY Change -70.45% -92.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $159.2K $163.6K
YoY Change 909.77% 937.6%
Total Long-Term Assets $612.3K $228.5K
YoY Change 20.61% -75.0%
TOTAL ASSETS
Total Short-Term Assets $2.130M $4.710M
Total Long-Term Assets $612.3K $228.5K
Total Assets $2.742M $4.938M
YoY Change -38.19% -30.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.256M $1.032M
YoY Change 138.45% 99.85%
Accrued Expenses $116.7K $98.95K
YoY Change -71.97% -77.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $4.540M $3.820M
YoY Change
Total Short-Term Liabilities $6.118M $5.063M
YoY Change 64.41% 35.56%
LONG-TERM LIABILITIES
Long-Term Debt $945.3K $1.630M
YoY Change
Other Long-Term Liabilities $280.7K
YoY Change
Total Long-Term Liabilities $1.226M $1.630M
YoY Change 39224.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.118M $5.063M
Total Long-Term Liabilities $1.226M $1.630M
Total Liabilities $7.344M $6.692M
YoY Change 97.35% 79.0%
SHAREHOLDERS EQUITY
Retained Earnings -$135.1M -$130.8M
YoY Change 13.76% 18.79%
Common Stock $86.37K $82.51K
YoY Change 64.96% 71.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.601M -$1.754M
YoY Change
Total Liabilities & Shareholders Equity $2.742M $4.938M
YoY Change -38.19% -30.84%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$4.103M -$5.398M
YoY Change 13.99% 9.48%
Depreciation, Depletion And Amortization $20.64K $19.65K
YoY Change -62.09% -80.72%
Cash From Operating Activities -$2.526M -$3.655M
YoY Change -4.15% 6.77%
INVESTING ACTIVITIES
Capital Expenditures $53.65K $0.00
YoY Change 37.78% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$53.65K $0.00
YoY Change 37.78% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 3.543M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.526M -3.655M
Cash From Investing Activities -53.65K 0.000
Cash From Financing Activities 0.000 3.543M
Net Change In Cash -2.580M -111.8K
YoY Change 12.3% -96.76%
FREE CASH FLOW
Cash From Operating Activities -$2.526M -$3.655M
Capital Expenditures $53.65K $0.00
Free Cash Flow -$2.580M -$3.655M
YoY Change -3.54% 5.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 knwn Authorized Shares Of Capital Common Stock
AuthorizedSharesOfCapitalCommonStock
200000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4709690 usd
CY2024Q1 knwn Net Working Capital
NetWorkingCapital
3466814 usd
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
3819660 usd
knwn Proceeds From Warrants Exercises
ProceedsFromWarrantsExercises
20808000 usd
CY2024Q1 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3661633 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4306520 usd
us-gaap Advertising Expense
AdvertisingExpense
104365 usd
us-gaap Advertising Expense
AdvertisingExpense
105045 usd
CY2024Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
4782621 usd
CY2023Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
7836393 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
29022016 shares
CY2024Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
2761939 shares
us-gaap Preferred Stock Dividends Shares
PreferredStockDividendsShares
160000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15019596 shares
CY2023Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
2255066 shares
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
213330 usd
CY2024Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21366 usd
CY2023Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21366 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
191738 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
153371 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81325 usd
us-gaap Depreciation
Depreciation
38367 usd
us-gaap Depreciation
Depreciation
205094 usd
us-gaap Lease Cost
LeaseCost
113305 usd
us-gaap Lease Cost
LeaseCost
146343 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8723 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5777 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
14500 usd
knwn Weighted Average Remaining Life Years
WeightedAverageRemainingLifeYears
P3Y10M24D
CY2024Q1 knwn Weighted Average Exercise Price Outstanding
WeightedAverageExercisePriceOutstanding
0.84
CY2024Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
9204304 shares
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.74
knwn Stock Option Grants
StockOptionGrants
29022106 shares
knwn Intrinsic Value
IntrinsicValue
6595047 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001074828
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82512166 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80358463 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48207937 shares
CY2023Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
48207937 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-30262
dei Entity Registrant Name
EntityRegistrantName
KNOW LABS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0273142
dei Entity Address Address Line1
EntityAddressAddressLine1
500 Union Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 810
dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Country
EntityAddressCountry
US
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98101
dei City Area Code
CityAreaCode
206
dei Local Phone Number
LocalPhoneNumber
903-1351
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
KNW
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
85512166 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4709690 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8023716 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
4709690 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
8023716 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55655 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81325 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
163628 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
15766 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9175 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
145090 usd
CY2024Q1 us-gaap Assets
Assets
4938148 usd
CY2023Q3 us-gaap Assets
Assets
8265897 usd
CY2024Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1031600 usd
CY2023Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1292861 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
98954 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
94062 usd
CY2024Q1 knwn Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
97822 usd
CY2023Q3 knwn Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
218334 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3819660 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2761931 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14500 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
154797 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5062536 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4521985 usd
CY2024Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1629586 usd
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2024Q1 us-gaap Liabilities
Liabilities
6692122 usd
CY2023Q3 us-gaap Liabilities
Liabilities
4521985 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82512166 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80358463 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
82512 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
80358 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
129008023 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
125501537 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130847314 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121840788 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1753974 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3743912 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4938148 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8265897 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2175245 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2563469 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3661633 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4306520 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2550848 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2242658 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4538657 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4147729 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
4726093 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
4806127 usd
us-gaap Operating Expenses
OperatingExpenses
8200290 usd
us-gaap Operating Expenses
OperatingExpenses
8454249 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4726093 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4806127 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8200290 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8454249 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
45243 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
0 usd
us-gaap Interest Income Other
InterestIncomeOther
96253 usd
us-gaap Interest Income Other
InterestIncomeOther
0 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
716814 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
124075 usd
us-gaap Interest Expense
InterestExpense
740251 usd
us-gaap Interest Expense
InterestExpense
298812 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-671571 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-124075 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-643998 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-298812 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5397664 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4930202 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8844288 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8753061 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5397664 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4930202 usd
us-gaap Net Income Loss
NetIncomeLoss
-8844288 usd
us-gaap Net Income Loss
NetIncomeLoss
-8753061 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
98609 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
162238 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5496273 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-4930202 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9006526 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8753061 usd
CY2024Q1 knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.07
CY2023Q1 knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.10
knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.11
knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.18
CY2024Q1 knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
81766128 shares
CY2023Q1 knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
48207937 shares
knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
81428231 shares
knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
48197581 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9862613 usd
CY2022Q4 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
744640 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2343 usd
CY2022Q4 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
12500 usd
CY2022Q4 knwn Expenses For Extension Of Notes And Warrants
ExpensesForExtensionOfNotesAndWarrants
206994 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-3822859 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7006231 usd
CY2023Q1 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
1182547 usd
CY2023Q1 knwn Expenses For Extension Of Notes And Warrants
ExpensesForExtensionOfNotesAndWarrants
142727 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4930202 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3401303 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3743912 usd
CY2023Q4 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
699246 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
26250 usd
CY2023Q4 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
203105 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-3446624 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1225889 usd
CY2024Q1 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
616317 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
170760 usd
CY2024Q1 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
0 usd
CY2024Q1 knwn Expenses For Extension Of Notes And Warrants
ExpensesForExtensionOfNotesAndWarrants
594761 usd
CY2024Q1 knwn Issuance Of Shares And Warrants In Connection With Debt Offering Amount
IssuanceOfSharesAndWarrantsInConnectionWithDebtOfferingAmount
1035963 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5397664 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1753974 usd
us-gaap Profit Loss
ProfitLoss
-8844288 usd
us-gaap Profit Loss
ProfitLoss
-8753061 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38367 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
205094 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1315563 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1927187 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
277010 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
135915 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
89612 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
100029 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
us-gaap Interest Expense Other
InterestExpenseOther
594761 usd
us-gaap Interest Expense Other
InterestExpenseOther
349721 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
147862 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1999 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-140297 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-92270 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-376882 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-64933 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7047684 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6340649 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12696 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41857 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12696 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41857 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3805699 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
203105 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
262450 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2343 usd
us-gaap Revenue Recognition Leases
RevenueRecognitionLeases
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Revenue Recognition</em></strong><strong> </strong>– The Company determines revenue recognition from contracts with customers through the following steps:</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the contract, or contracts, with the customer;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the performance obligations in the contract;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">determination of the transaction price;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">allocation of the transaction price to the performance obligations in the contract; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">recognition of the revenue when, or as, the Company satisfies a performance obligation.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.</p>
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
12500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3746354 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14843 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3314026 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6367663 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8023716 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12593692 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4709690 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6226029 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
162238 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
knwn Warrants Issued For Debt Offering
WarrantsIssuedForDebtOffering
1536743 usd
knwn Warrants Issued For Debt Offering
WarrantsIssuedForDebtOffering
0 usd
CY2024Q1 knwn Authorized Shares Of Capital Stock
AuthorizedSharesOfCapitalStock
205000000 shares
knwn Sell Shares Of Common Stock
SellSharesOfCommonStock
5000000 usd
us-gaap Derivatives Methods Of Accounting Hedge Effectiveness
DerivativesMethodsOfAccountingHedgeEffectiveness
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Derivative Financial Instruments</em></strong><strong> – </strong>Pursuant to ASC 815 “Derivatives and Hedging”, the Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company then determines if an embedded derivative must be bifurcated and separately accounted for. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the unaudited consolidated balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined that the conversion features for purposes of bifurcation within its currently outstanding convertible notes payable were immaterial and there was no derivative liability to be recorded as of March 31, 2024 and 2023.</p>
CY2024Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
82512166 shares
CY2024Q1 knwn Issuable Upon Conversion Of Common Stock
IssuableUponConversionOfCommonStock
4800000 shares
CY2024Q1 knwn Issuable Upon Conversion Of Common Stocks
IssuableUponConversionOfCommonStocks
4800000 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Use of Estimates</em></strong> – The preparation of unaudited consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
226027 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55655 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
14500 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
154797 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9175 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
145090 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07 pure
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5449246 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2761931 usd
CY2024Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1629586 usd
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2024Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
3819659 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2761931 usd
CY2024Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
5449246 usd
CY2023Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
2761931 usd
CY2024Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
97822 usd
CY2023Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
94062 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
230005 usd
knwn Note Shares And Warrant Shares Upon Repayment Or Conversion Of Notes And Exercise Of Warrants Description
NoteSharesAndWarrantSharesUponRepaymentOrConversionOfNotesAndExerciseOfWarrantsDescription
Issuance of Note Shares and Warrant Shares upon repayment or conversion of Notes and exercise of Warrants is subject to an ownership limitation equal to 4.99% of the Company’s outstanding shares of common stock; provided, that if Lind and its affiliates beneficially own in excess of 4.99% of the Company’s outstanding shares of common stock, then such limitation shall automatically increase to 9.99% so long as Lind and its affiliates own in excess of 4.99% of such common stock (and shall, for the avoidance of doubt, automatically decrease to 4.99% upon Lind and its affiliates ceasing to own in excess of 4.99% of such common stock
us-gaap Interest Expense Debt
InterestExpenseDebt
250000 usd
us-gaap Recapitalization Costs
RecapitalizationCosts
15000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3805699 usd
CY2024Q1 knwn Issuable Upon Conversion Of Common Stock
IssuableUponConversionOfCommonStock
4800000 shares
knwn Warrant Shares
WarrantShares
3000000 shares
knwn Warrant Amount
WarrantAmount
1563743 usd
knwn Securities Purchase Agreement Description
SecuritiesPurchaseAgreementDescription
the Company incurred approximately $994,000 of issuance costs of which $675,971 were allocated to the Note and $318,330 to the Warrant Shares. The amount allocated to the Notes was recorded as debt discount (with an offset to APIC) and will be amortized over the two-year term of the Notes
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
100029 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
9020264 shares
CY2024Q1 knwn Description Of Automatic Conversion Of Convertible
DescriptionOfAutomaticConversionOfConvertible
the Company issued 102,302 shares of the Company’s common stock at $0.782 with a total value of $80,000 per share related to a debt offering. The $80,000 was recorded as debt issuance costs and is amortized over the two-year term of the debt
knwn Cashless Warrant Exercise
CashlessWarrantExercise
714828 shares
CY2023Q3 knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbers
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbers
20866313 shares
CY2023Q3 knwn Outstanding At Begenning Of Period
OutstandingAtBegenningOfPeriod
1.06
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3123648 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.78
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
714828 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
290172 shares
knwn Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInWeightedAverageExercisePrice
0.45
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbe
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbe
22984961 shares
CY2024Q1 knwn Outstanding At End Of Period
OutstandingAtEndOfPeriod
1.06
CY2024Q1 knwn Exercisable At End Of Period
ExercisableAtEndOfPeriod
22984961 shares
srt Federal Funds Sold Average Yield
FederalFundsSoldAverageYield
0 pure
knwn Expected Life Plants Useful Life
ExpectedLifePlantsUsefulLife
P3Y
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
1.05 pure
us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.0432 pure
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
22984961 usd
knwn Sharebased Compensation Arrangements By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementsBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
3339451 usd
knwn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned
16340548 shares
CY2024Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.29
CY2024Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
29022106 shares
srt Federal Funds Sold Average Yield
FederalFundsSoldAverageYield
0 pure
knwn Expected Life Plants Useful Life
ExpectedLifePlantsUsefulLife
P3Y
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
1.05 pure
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
CY2017Q2 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
2908 usd
CY2017Q2 knwn Lease Description
LeaseDescription
The Company expects to vacate the office on May 31, 2024
CY2021Q2 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
8697 usd
CY2021Q2 knwn Lease Description
LeaseDescription
the lease was terminated on February 5, 2024
CY2021Q4 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
5000 usd
CY2021Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-12-31
CY2022Q4 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
2250 usd
CY2022Q4 knwn Lease Description
LeaseDescription
The Company expects to vacate the office on May 31, 2024
CY2024Q1 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
11492 usd
CY2024Q1 knwn Lease Description
LeaseDescription
increases at 3% annually after year one. The lease commences on May 1, 2024 and terminates on July 31, 2027

Files In Submission

Name View Source Status
0001654954-24-006410-index-headers.html Edgar Link pending
0001654954-24-006410-index.html Edgar Link pending
0001654954-24-006410.txt Edgar Link pending
0001654954-24-006410-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
knwn-20240331.xsd Edgar Link pending
knwn_10q.htm Edgar Link pending
knwn_10qimg38.jpg Edgar Link pending
knwn_ex311.htm Edgar Link pending
knwn_ex312.htm Edgar Link pending
knwn_ex321.htm Edgar Link pending
knwn_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
knwn-20240331_def.xml Edgar Link unprocessable
knwn-20240331_lab.xml Edgar Link unprocessable
knwn-20240331_pre.xml Edgar Link unprocessable
knwn_10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
knwn-20240331_cal.xml Edgar Link unprocessable